Pediatric Dermatology

COVID-19 Skin Symptoms in Children
October 22, 2021

Lawrence Eichenfield, MD, provides the newest updates in pediatric patient care, with a special update on COVID-19 skin symptoms in children.

If Approved, Cantharidin 0.7% Could be Standard of Molluscum Care
October 21, 2021

Cantharidin 0.7% could be an emerging standard for molluscum treatment.

Latest on Infectious Disease at Maui Derm
October 01, 2021

Ted Rosen, MD, and Sheila Fallon Friedlander, MD, discuss infectious disease updates at the virtual Maui Derm NP+PA Fall 2021 conference.

Latest News on Atopic Dermatitis in Children
September 30, 2021

At Maui Derm NP+PA Fall 2021, Vikash S. Oza, MD, and Matthew J. Zirwas, MD, discuss the current Rx and Dx of atopic dermatitis in children.

French Results Echo Expert Findings
September 03, 2021

According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.

PeDRA Lists Systemics With Higher COVID-19 Risk
September 02, 2021

Some systemic medications may have increased risk for patients during the COVID-19 era, according to a recent Pediatric Dermatology Research Alliance (PeDRA) statement.

Transform Pandemic Lessons Into Actionable Care Plans
September 01, 2021

COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.

Comparing Pediatric and Adult Hidradenitis Suppurativa Patients
August 27, 2021

Many conditions are different in the pediatric population than in the adult population. How does hidradenitis suppurativa differ between the 2 groups?

Abrocitinib and Topical Therapy Safe, Effective for Atopic Dermatitis in Teens
August 23, 2021

A phase 3 trial studied the effectiveness of oral abrocitinib along with topical therapy for moderate-to-severe atopic dermatitis in teens.

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
August 05, 2021

In this episode, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).